Law360 reported that a Morgan Lewis team is representing Zimmer Biomet Holdings Inc. and its current and former officers and directors in a derivative lawsuit that followed a contentious securities class action concerning alleged US FDA compliance issues at one of the company’s lead manufacturing facilities in Indiana.
Zimmer Biomet Holdings Inc. and the current and former officers and directors are represented by partners Troy Brown and Laura Hughes McNally, and of counsel John Barillare.